Annual Total Long Term Liabilities
$495.00 K
-$164.00 K-24.89%
December 31, 2023
Summary
- As of February 26, 2025, AIM annual total long term liabilities is $495.00 thousand, with the most recent change of -$164.00 thousand (-24.89%) on December 31, 2023.
- During the last 3 years, AIM annual total long term liabilities has fallen by -$1.69 million (-77.38%).
- AIM annual total long term liabilities is now -92.00% below its all-time high of $6.18 million, reached on December 31, 2019.
Performance
AIM Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$576.00 K
-$195.00 K-25.29%
September 30, 2024
Summary
- As of February 26, 2025, AIM quarterly total long term liabilities is $576.00 thousand, with the most recent change of -$195.00 thousand (-25.29%) on September 30, 2024.
- Over the past year, AIM quarterly long term liabilities has stayed the same.
- AIM quarterly long term liabilities is now -94.21% below its all-time high of $9.95 million, reached on March 31, 2019.
Performance
AIM Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
AIM Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -24.9% | 0.0% |
| 3 y3 years | -77.4% | -3.5% |
| 5 y5 years | -85.3% | -3.5% |
AIM Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -24.9% | +236.7% | -61.3% | +554.5% |
| 5 y | 5-year | -92.0% | +236.7% | -91.3% | +554.5% |
| alltime | all time | -92.0% | +1646.9% | -94.2% | +676.0% |
AIM ImmunoTech Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $576.00 K(-25.3%) |
| Jun 2024 | - | $771.00 K(-48.2%) |
| Mar 2024 | - | $1.49 M(+200.4%) |
| Dec 2023 | $495.00 K(-24.9%) | $495.00 K(-8.8%) |
| Sep 2023 | - | $543.00 K(-9.0%) |
| Jun 2023 | - | $597.00 K(-6.1%) |
| Mar 2023 | - | $636.00 K(-3.5%) |
| Dec 2022 | $659.00 K(+348.3%) | $659.00 K(-5.2%) |
| Sep 2022 | - | $695.00 K(-5.6%) |
| Jun 2022 | - | $736.00 K(+736.4%) |
| Mar 2022 | - | $88.00 K(-40.1%) |
| Dec 2021 | $147.00 K(-93.3%) | $147.00 K(-44.7%) |
| Sep 2021 | - | $266.00 K(-15.3%) |
| Jun 2021 | - | $314.00 K(-85.4%) |
| Mar 2021 | - | $2.15 M(-1.6%) |
| Dec 2020 | $2.19 M(-64.6%) | $2.19 M(-3.1%) |
| Sep 2020 | - | $2.26 M(-1.8%) |
| Jun 2020 | - | $2.30 M(-65.1%) |
| Mar 2020 | - | $6.59 M(+6.6%) |
| Dec 2019 | $6.18 M(+83.0%) | $6.18 M(+38.8%) |
| Sep 2019 | - | $4.46 M(-19.2%) |
| Jun 2019 | - | $5.51 M(-44.6%) |
| Mar 2019 | - | $9.95 M(+194.4%) |
| Dec 2018 | $3.38 M(+20.8%) | $3.38 M(-10.3%) |
| Sep 2018 | - | $3.77 M(-16.5%) |
| Jun 2018 | - | $4.51 M(+32.3%) |
| Mar 2018 | - | $3.41 M(+21.9%) |
| Dec 2017 | $2.80 M(+197.6%) | $2.80 M(+12.6%) |
| Sep 2017 | - | $2.48 M(-18.1%) |
| Jun 2017 | - | $3.03 M(+137.1%) |
| Mar 2017 | - | $1.28 M(+36.1%) |
| Dec 2016 | $940.00 K(>+9900.0%) | $940.00 K(-62.6%) |
| Sep 2016 | - | $2.51 M(>+9900.0%) |
| Jun 2016 | - | $0.00(0.0%) |
| Mar 2016 | - | $0.00(0.0%) |
| Dec 2015 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2015 | - | $0.00(0.0%) |
| Jun 2015 | - | $0.00(0.0%) |
| Mar 2015 | - | $0.00(0.0%) |
| Dec 2014 | $0.00 | $0.00(-100.0%) |
| Sep 2014 | - | $16.00 K(-20.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2014 | - | $20.00 K(-31.0%) |
| Mar 2014 | - | $29.00 K(-21.6%) |
| Dec 2013 | $37.00 K(-89.4%) | $37.00 K(-61.9%) |
| Sep 2013 | - | $97.00 K(-31.2%) |
| Jun 2013 | - | $141.00 K(-43.8%) |
| Mar 2013 | - | $251.00 K(-28.3%) |
| Dec 2012 | $350.00 K(-26.9%) | $350.00 K(-83.9%) |
| Sep 2012 | - | $2.18 M(+902.8%) |
| Jun 2012 | - | $217.00 K(-64.8%) |
| Mar 2012 | - | $617.00 K(+28.8%) |
| Dec 2011 | $479.00 K(-83.5%) | $479.00 K(-64.8%) |
| Sep 2011 | - | $1.36 M(-31.5%) |
| Jun 2011 | - | $1.98 M(-31.6%) |
| Mar 2011 | - | $2.90 M(0.0%) |
| Dec 2010 | $2.90 M(-21.3%) | $2.90 M(+2490.2%) |
| Sep 2010 | - | $112.00 K(+433.3%) |
| Jun 2010 | - | $21.00 K(-30.0%) |
| Mar 2010 | - | $30.00 K(-99.2%) |
| Dec 2009 | $3.68 M(>+9900.0%) | $3.68 M(>+9900.0%) |
| Sep 2009 | - | $0.00(0.0%) |
| Jun 2009 | - | $0.00(0.0%) |
| Mar 2009 | - | $0.00(0.0%) |
| Dec 2008 | $0.00(-100.0%) | $0.00(-100.0%) |
| Mar 2006 | - | $3.52 M(-15.5%) |
| Dec 2005 | $4.17 M(+2118.6%) | $4.17 M(+2204.4%) |
| Mar 2005 | - | $181.00 K(-3.7%) |
| Dec 2004 | $188.00 K(-92.6%) | $188.00 K(-80.4%) |
| Sep 2004 | - | $958.00 K(-53.4%) |
| Jun 2004 | - | $2.06 M(-33.3%) |
| Mar 2004 | - | $3.08 M(+20.9%) |
| Dec 2003 | $2.55 M(>+9900.0%) | $2.55 M(-0.8%) |
| Sep 2003 | - | $2.57 M(>+9900.0%) |
| Jun 2003 | - | $0.00(-100.0%) |
| Mar 2003 | - | $1.30 M(>+9900.0%) |
| Dec 2002 | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2002 | - | $0.00(0.0%) |
| Jun 2002 | - | $0.00(-100.0%) |
| Dec 1999 | -$32.00 K | -$32.00 K(-68.0%) |
| Jun 1997 | - | -$100.00 K(-150.0%) |
| Jun 1996 | - | $200.00 K(+100.0%) |
| Mar 1996 | - | $100.00 K |
FAQ
- What is AIM ImmunoTech annual total long term liabilities?
- What is the all time high annual total long term liabilities for AIM ImmunoTech?
- What is AIM ImmunoTech annual total long term liabilities year-on-year change?
- What is AIM ImmunoTech quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for AIM ImmunoTech?
- What is AIM ImmunoTech quarterly long term liabilities year-on-year change?
What is AIM ImmunoTech annual total long term liabilities?
The current annual total long term liabilities of AIM is $495.00 K
What is the all time high annual total long term liabilities for AIM ImmunoTech?
AIM ImmunoTech all-time high annual total long term liabilities is $6.18 M
What is AIM ImmunoTech annual total long term liabilities year-on-year change?
Over the past year, AIM annual total long term liabilities has changed by -$164.00 K (-24.89%)
What is AIM ImmunoTech quarterly total long term liabilities?
The current quarterly long term liabilities of AIM is $576.00 K
What is the all time high quarterly long term liabilities for AIM ImmunoTech?
AIM ImmunoTech all-time high quarterly total long term liabilities is $9.95 M
What is AIM ImmunoTech quarterly long term liabilities year-on-year change?
Over the past year, AIM quarterly total long term liabilities has changed by $0.00 (0.00%)